PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 171 filers reported holding PRECIGEN INC in Q4 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8 | +33.3% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $6 | 0.0% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $6 | -45.5% | 6,000 | -20.3% | 0.00% | 0.0% |
| Q4 2022 | $11 | -99.9% | 7,526 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $15,000 | +50.0% | 7,526 | -7.4% | 0.00% | 0.0% |
| Q2 2022 | $10,000 | -37.5% | 8,126 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $16,000 | -56.8% | 8,126 | -56.6% | 0.00% | 0.0% |
| Q4 2021 | $37,000 | -15.9% | 18,726 | +14.9% | 0.00% | -50.0% |
| Q3 2021 | $44,000 | +12.8% | 16,300 | +61.4% | 0.00% | 0.0% |
| Q2 2021 | $39,000 | -4.9% | 10,100 | +68.3% | 0.00% | 0.0% |
| Q1 2021 | $41,000 | -42.3% | 6,000 | -62.7% | 0.00% | -33.3% |
| Q4 2020 | $71,000 | +77.5% | 16,100 | -24.8% | 0.00% | +50.0% |
| Q3 2020 | $40,000 | -35.5% | 21,400 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $62,000 | +47.6% | 21,400 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $42,000 | – | 21,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |